Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recruiting Blood Donor With Allogeneic Natural Killer Cell Which Will be Used for HCC After TACE

NCT02716571 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT02716571
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02716571 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recruiting Blood Donor With Allogeneic Natural Killer Cell Which Will be Used for HCC After TACE
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 28, 2016
Completion date
July 27, 2017
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers